{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2010"],"condition":["Adenocarcinoma","Sarcoma","Mesothelioma","Solid Organ Tumors"],"disease":["Adenocarcinoma","Sarcoma","Mesothelioma","Solid Organ Tumors"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2100449"],"location":["United States"],"study_start_month":["11"],"keyword":["Peritoneal","Colorectal","Endometrial","Lung","Ovarian","Vulva","Persistent","Recurrent","Assay","Uterine Neoplasms","Fallopian Tube","Chemotherapy","Cervical","Breast","Carcinoid","Chemoresponse"],"repository":["ECRIN MDR"],"study_status":["Terminated"],"additional_accession":[]},"is_claimable":false,"name":"A Study of ChemoFx Chemoresponse Assay in Solid Tumors - ChemoFx Registry Study","description":"The purpose of this research study is to collect information from patient’s medical records that had a test called ChemoFx ordered and to understand how doctors may have used the results of the ChemoFx to treat patients with cancer.","dates":{"creation":"2010-11-15"},"accession":"2100449","cross_references":{"ClinicalTrials___gov":["NCT01271959"]}}